Browse diseases

…ugh 50 weeks in participants with moderately to severely active ulcerative colitis (UC) in the phase 2, double-blind, placebo-controlled ARTEMIS-U…

…t-through, dose-ranging study in adults with moderate to severe ulcerative colitis (UC). Here we report W28 ANTHEM-UC efficacy and safety.Methods …

…b-study within the multicentre MUSIC cohort. Adults with active ulcerative colitis (UC) or colonic/ileocolonic Crohn’s disease (CD) provided paire…

…Introduction Unlike some advanced therapies for Ulcerative Colitis (UC), upadacitinib (upa), a selective JAK1 inhibitor, is effect…

…Introduction Inflammatory bowel disease (IBD) confers an increased lifetime risk of colorectal cancer (…

…terns that do not align with the conventional classification of ulcerative colitis (UC), Crohn’s disease (CD), or IBD unclassified (IBDu). We aime…

…tor approved for the treatment of moderately to severely active ulcerative colitis (UC). The impact of concomitant 5-aminosalicyclate acid (5-ASA)…

…leton pregnancies were included:128(52.0%) Crohn’s, 105 (42.7%) Ulcerative Colitis and 13 (5.9%) IBD-U.Women with active disease at pre-conception…

…se results demonstrate increased levels of protease activity in IBD patients relative to HC. They also show higher levels in IBD pa…

…s in medical therapy, a substantial proportion of patients with ulcerative colitis (UC) still require surgery, often early in the disease course. …

…n Prebiotics in Reducing Inflammation and Clinical Endpoints in Ulcerative Colitis (PRInCE-UC) was an adequately powered, randomised double-blind …

…or 51.1% of patients. Patients predominantly had a diagnosis of ulcerative colitis (n=994), followed by Crohn’s disease (n=409) and IBD-unclassifi…